Compare REAL & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REAL | INSP |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2019 | 2018 |
| Metric | REAL | INSP |
|---|---|---|
| Price | $9.30 | $52.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 16 |
| Target Price | $17.00 | ★ $101.07 |
| AVG Volume (30 Days) | ★ 3.5M | 1.0M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.55 | ★ 179.43 |
| EPS | N/A | ★ 4.89 |
| Revenue | ★ $692,845,000.00 | $82,050,000.00 |
| Revenue This Year | $14.30 | $8.44 |
| Revenue Next Year | $10.19 | $8.60 |
| P/E Ratio | ★ N/A | $11.02 |
| Revenue Growth | 15.38 | ★ 62.18 |
| 52 Week Low | $4.61 | $53.11 |
| 52 Week High | $17.39 | $172.95 |
| Indicator | REAL | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 34.66 | 29.73 |
| Support Level | $7.21 | N/A |
| Resistance Level | $11.48 | $84.26 |
| Average True Range (ATR) | 0.57 | 2.82 |
| MACD | -0.07 | -0.05 |
| Stochastic Oscillator | 19.06 | 8.88 |
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.